 - atorvastatin 10 mg monotherapy for 4 weeks or longer before the start of the 4-week washout and low density lipoprotein-cholesterol LDL-C levels that had not reached the following lipid management target values during treatment: Category I low-risk group with no other risk factors - LDL-C 160 mgdL; Category II mid-risk group with 1-2 risk factors other than LDL-C levels - LDL-C 140 mgdL; Category III high-risk group with 3 or more other risk factors - LDL-C 120 mgdL; and for participants with history of coronary artery disease - LDL-C 100 mgdL. 